# Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline Study Guide This study guide is based on the 2023 Evidence-Based Clinical Practice Guideline developed by the American Academy of Orthopaedic Surgeons (AAOS). It provides a synthesis of recommendations for the management of symptomatic hip osteoarthritis (OA) in adults, covering both non-surgical and surgical interventions. --- ## Part 1: Key Concepts and Recommendations The AAOS uses the GRADE Evidence-to-Decision (EtD) Framework to categorize the strength of its findings. Recommendations are directional statements based on sufficient evidence, while "Options" are based on limited or consensus-level evidence. ### Pharmacological Management * **NSAIDs (Oral):** Strongly recommended for reducing pain and improving function, provided there are no contraindications. * **Acetaminophen (Oral):** Considered a consensus option; the workgroup suggests it may be used to improve pain and function in the absence of contraindications. * **Prescription Opioids:** The workgroup reached a consensus opinion that oral opioids should **not** be utilized for the nonoperative treatment of symptomatic hip OA. * **Intraarticular Hyaluronic Acid:** Strongly recommended **against**. Evidence suggests it does not improve function or reduce pain better than a placebo. * **Intraarticular Corticosteroid Injection:** Recommended (Moderate strength) for short-term improvement in function and pain. ### Physical Therapy (PT) * **Conservative Treatment:** Physical therapy is recommended for patients with mild to moderate symptomatic OA to improve function and reduce pain. * **Postoperative Treatment:** High-quality evidence supports both formal physical therapy and unsupervised home exercise after Total Hip Arthroplasty (THA). There is no evidence that unsupervised exercise is superior to formal PT. ### Surgical Interventions and Perioperative Care * **Tranexamic Acid (TXA):** Strongly recommended for THA patients (IV or topical) to reduce blood loss and the need for blood transfusions. * **Femoral Fixation:** In older adults, cemented femoral stems may be considered to reduce the risk of periprosthetic fractures. * **Exposure Approach:** There is no preferred surgical approach; each (e.g., anterior, posterior) has specific risks and benefits. * **Anesthesia:** Neuraxial anesthesia may be preferred over general anesthesia to reduce the risk of adverse events. ### Patient Factors and Risks | Factor | Clinical Finding | Strength of Evidence | | :--- | :--- | :--- | | **Elevated BMI** | May increase risk of adverse events and result in lower absolute outcome scores (though improvement magnitude remains similar). | Limited | | **Diabetes** | Poorly controlled diabetes increases the risk of adverse events after THA. | Limited | | **Tobacco Use** | Increases the risk of adverse events following THA. | Limited | | **Stiff Spine Syndrome** | Increases the risk of dislocation after THA. | Consensus/Low | | **Social Determinants** | Factors like income, education, and insurance type impact length of stay, cost, and mortality. | Limited | --- ## Part 2: Short-Answer Practice Questions **1. What is the primary clinical reason for recommending Tranexamic Acid (TXA) during a total hip arthroplasty?** *Answer:* TXA is recommended to reduce perioperative blood loss and minimize the requirement for blood transfusions. **2. Why was the recommendation for postoperative physical therapy downgraded to "Moderate" despite high-quality evidence?** *Answer:* The recommendation was downgraded due to heterogeneity in the duration, timeframe, frequency, and types of modalities used in the studies, making direct comparisons difficult. **3. Does the AAOS recommend intraarticular hyaluronic acid for hip OA? Why or why not?** *Answer:* No. It is strongly recommended against because evidence indicates it is no more effective than a placebo in improving function or reducing pain. **4. What is the consensus regarding the use of oral opioids for nonoperative hip OA treatment?** *Answer:* The guideline workgroup's clinical opinion is that oral opioids should not be used for nonoperative treatment. **5. How does "stiff spine syndrome" affect the outcomes of a total hip arthroplasty?** *Answer:* Patients with stiff spine syndrome may face an increased risk of dislocation after the procedure. **6. For which patient demographic might cemented femoral fixation be preferred, and why?** *Answer:* Older adult patients; cemented stems are associated with a lower risk of periprosthetic fracture compared to cementless options. --- ## Part 3: Essay Prompts for Deeper Exploration **1. The Role of Patient-Specific Modifiable Risks in THA Outcomes** Discuss how modifiable risk factors—specifically BMI, tobacco use, and glycemic control (diabetes)—impact the safety and efficacy of total hip arthroplasty. Based on the guideline, how should clinicians approach shared decision-making with patients who present with these risks? **2. Comparative Efficacy of Physical Therapy Modalities** Analyze the guideline's stance on supervised physical therapy versus unsupervised home exercise. Explore the benefits and potential harms of implementing a home-only program, and discuss why the workgroup emphasizes the need for future research into which specific patient populations benefit most from formal PT. **3. Navigating Pharmacological Options for Hip Osteoarthritis** Evaluate the hierarchy of pharmacological treatments provided in the guideline. Contrast the "Strong" recommendation for NSAIDs against the "Consensus" for Acetaminophen and the "Strong" recommendation against Hyaluronic Acid. What does this suggest about the current state of clinical evidence in hip OA drug therapy? --- ## Part 4: Glossary of Important Terms * **CPG (Clinical Practice Guideline):** A statement produced by a physician volunteer group based on a formal systematic review of scientific and clinical information to assist in treatment decisions. * **Evidence-to-Decision (EtD) Framework:** A systematic process used by the AAOS to move from evidence to recommendations, incorporating factors like benefits/harms, costs, and patient preferences. * **Heterogeneity:** In the context of clinical studies, refers to the diversity or lack of uniformity in study methods, participants, or interventions (e.g., different types of physical therapy). * **Neuraxial Anesthesia:** A type of anesthesia (such as spinal or epidural) that targets the nerves of the central nervous system, suggested by limited evidence to reduce adverse events in THA. * **PICO Questions:** A framework used to define the scope of a literature search, standing for Population, Intervention, Comparison, and Outcome. * **Symptomatic Osteoarthritis:** OA that presents with clinical symptoms, primarily pain and functional impairment, interfering with the patient's quality of life. * **Total Hip Arthroplasty (THA):** A surgical procedure to replace a damaged hip joint with an artificial prosthesis. * **Tranexamic Acid (TXA):** An antifibrinolytic agent used perioperatively to reduce blood loss.